Edition:
United Kingdom

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

320.00SEK
15 Dec 2017
Change (% chg)

-2.50kr (-0.78%)
Prev Close
322.50kr
Open
332.50kr
Day's High
332.50kr
Day's Low
317.00kr
Volume
4,559
Avg. Vol
22,629
52-wk High
613.00kr
52-wk Low
290.00kr

Latest Key Developments (Source: Significant Developments)

Probi Signs Agreement For Product Launch In North America
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - PROBI ::SIGNED MAJOR AGREEMENT FOR LAUNCH OF FUNCTIONAL FOOD PRODUCT IN NORTH AMERICA.- ‍AGREEMENT IS EXPECTED TO HAVE SIGNIFICANT IMPACT ON FUTURE REVENUES AND EARNINGS IN PROBI'S FUNCTIONAL FOOD BUSINESS AREA​.‍LAUNCH OF PRODUCT IS PLANNED FOR SECOND HALF OF 2019 IN NORTH AMERICAN MARKET​.  Full Article

Probi Q3 operating profit down at SEK 16.6‍​ million
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - PROBI ::Q3 NET SALES SEK ‍​133.5 MILLION VERSUS SEK 89.2 MILLION YEAR AGO.Q3 OPERATING PROFIT SEK 16.6‍​ MILLION VERSUS SEK 30.7 MILLION YEAR AGO.  Full Article

Probi says no longer expects to hit organic growth goal in 2017
Monday, 4 Sep 2017 

STOCKHOLM, Sept 4 (Reuters) - Probi : :Says goal to organically grow faster than the global market is unlikely to be met in 2017.Says has been informed that one of its largest customers in the North American market is continuing its previously introduced destocking program, now as a result of over purchases and safety stock reduction.Says it is expected that the destocking will continue during the second half of 2017 and the first quarter of 2018.Says it is expected that this will affect net sales negatively with approximately MSEK 50 per quarter over said period compared with corresponding periods 2016 and 2017.  Full Article

Probi decides on rights issue and announces terms
Thursday, 29 Sep 2016 

Probi AB : Decides on rights issue and announces terms . Rights issue comprises no more than 2,278,825 shares . Total issue proceeds of about 602 million Swedish crowns ($70.30 million) before issue costs, assuming that rights issue is fully subscribed .Subscription price has been set to 264 crowns per new share.  Full Article

Probi Q2 operating profit up at SEK 20.7 million
Friday, 15 Jul 2016 

Probi AB : Q2 net sales 73.3 million Swedish crowns ($8.6 million) versus 59.0 million crowns year ago .Q2 operating profit 20.7 million crowns versus 15.7 million crowns year ago.  Full Article

Probi to buy Nutraceutix and expand into North American market
Tuesday, 7 Jun 2016 

Probi AB : Probi to acquire Nutraceutix, expanding its North American presence and capabilities . Announces rights issue of about 600 million Swedish crowns ($74 million) . To acquire Nutraceutix for a preliminary cash purchase price of $105 million (873 million Swedish crowns) on a cash and debt free basis . Will increase its market share in North America more than three-fold . Cash purchase price will be financed through available cash reserves, a credit facility of about $35 million and a bridge facility of about $63 million . Handelsbanken has committed to provide the credit facility and the bridge facility .Bridge facility will be repaid by proceeds from the rights issue of about 600 million crowns.  Full Article

Probi to buy Nutraceutix and expand into North American market
Monday, 6 Jun 2016 

Probi AB : Probi to acquire Nutraceutix, expanding its North American presence and capabilities . Announces rights issue of about 600 million Swedish crowns ($74 million) . To acquire Nutraceutix for a preliminary cash purchase price of $105 million (873 million Swedish crowns) on a cash and debt free basis . Will increase its market share in North America more than three-fold . Cash purchase price will be financed through available cash reserves, a credit facility of about $35 million and a bridge facility of about $63 million . Handelsbanken has committed to provide the credit facility and the bridge facility .Bridge facility will be repaid by proceeds from the rights issue of about 600 million crowns.  Full Article

Probi signs new agreements in Functional Food and Consumer Healthcare
Tuesday, 31 May 2016 

Probi AB : Signs new agreements in Functional Food and Consumer Healthcare . Has signed agreements with three different partners in Sweden, Iceland and Austria .European launch is planned for second half of 2016.  Full Article

Probi AB signs primary care distribution agreement with Ipsen
Tuesday, 26 Apr 2016 

Probi AB:Probi and Ipsen sign primary care distribution agreement for probiotic LP299V, Lactobacillus plantarum 299v.Agreement covers 18 countries, primarily within EU and emerging markets.Probi will supply bulk LP299V capsules and Ipsen will be responsible for packaging, marketing and selling product.Product is expected to be launched in H1 2017 as a food supplement in European markets.Product is expected to be launched in other key markets such as Russia and China, depending on regulatory approval.  Full Article

Probi announces changed dividend policy effective 2016 financial year
Monday, 4 Apr 2016 

Probi AB:Announces changed dividend policy effective 2016 financial year.In future, dividend will be based on Probi's earnings level and financial position, as well as requirements for financing of investment opportunities.Goal is to pay a dividend of 30-50 pct of profit after tax.  Full Article

BRIEF-Probi Signs Agreement For Product Launch In North America

* SIGNED MAJOR AGREEMENT FOR LAUNCH OF FUNCTIONAL FOOD PRODUCT IN NORTH AMERICA